BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gamboa AC, Liu Y, Lee RM, Zaidi MY, Staley CA, Kooby DA, Winer JH, Shah MM, Russell MC, Cardona K, Maithel SK. Duodenal neuroendocrine tumors: Somewhere between the pancreas and small bowel? J Surg Oncol 2019;120:1293-301. [PMID: 31621090 DOI: 10.1002/jso.25731] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Folkestad O, Wasmuth HH, Mjønes P, Fougner R, Hauso Ø, Fossmark R. Survival and Disease Recurrence in Patients with Duodenal Neuroendocrine Tumours-A Single Centre Cohort. Cancers (Basel) 2021;13:3985. [PMID: 34439140 DOI: 10.3390/cancers13163985] [Reference Citation Analysis]
2 Li J, Huang WF, Zhang JY. A rare case of duodenal neuroendocrine tumor with hepatic metastasis. Clin Res Hepatol Gastroenterol 2021;:101850. [PMID: 34923182 DOI: 10.1016/j.clinre.2021.101850] [Reference Citation Analysis]
3 Borbath I, Pape UF, Deprez PH, Bartsch DK, Caplin M, Falconi M, Garcia-Carbonero R, Grozinsky-Glasberg S, Jensen RT, Arnold R, Ruszniewski P, Toumpanakis C, Valle JW, O Toole D; Members of the Advisory Board of the European Neuroendocrine Tumor Society (ENETS). ENETS standardized (synoptic) reporting for endoscopy in neuroendocrine tumors. J Neuroendocrinol 2022;:e13105. [PMID: 35233848 DOI: 10.1111/jne.13105] [Reference Citation Analysis]
4 Sun S, Wang W, He C. Development and Validation of Prognostic Nomograms for Patients with Duodenal Neuroendocrine Neoplasms. Med Sci Monit 2020;26:e922613. [PMID: 32564052 DOI: 10.12659/MSM.922613] [Reference Citation Analysis]
5 Rossi RE, Milanetto AC, Andreasi V, Campana D, Coppa J, Nappo G, Rinzivillo M, Invernizzi P, Modica R, David A, Partelli S, Lamberti G, Mazzaferro V, Zerbi A, Panzuto F, Pasquali C, Falconi M, Massironi S; ItaNet (Italian Association for Neuroendocrine Tumours) study group. Risk of preoperative understaging of duodenal neuroendocrine neoplasms: a plea for caution in the treatment strategy. J Endocrinol Invest 2021;44:2227-34. [PMID: 33651317 DOI: 10.1007/s40618-021-01528-1] [Reference Citation Analysis]
6 Klemm N, Lu-Cleary D, Chahal D, Trasolini R, Lam E, Donnellan F. Endoscopic Management of Diminutive Duodenal Neuroendocrine Tumors. J Gastrointest Cancer 2021;52:448-53. [PMID: 33471257 DOI: 10.1007/s12029-020-00577-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Christou N, Auger C, Battu S, Lalloué F, Jauberteau-Marchan MO, Hervieu C, Verdier M, Mathonnet M. Intraperitoneal Chemotherapy for Peritoneal Metastases: Technical Innovations, Preclinical and Clinical Advances and Future Perspectives. Biology (Basel) 2021;10:225. [PMID: 33804167 DOI: 10.3390/biology10030225] [Reference Citation Analysis]
8 Tran CG, Sherman SK, Suraju MO, Nayyar A, Gerke H, Abiad RGE, Chandrasekharan C, Ear PH, O'Dorisio TM, Dillon JS, Bellizzi AM, Howe JR. Management of Duodenal Neuroendocrine Tumors: Surgical versus Endoscopic Mucosal Resection. Ann Surg Oncol 2021. [PMID: 34515889 DOI: 10.1245/s10434-021-10774-9] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Ruff SM, Standring O, Wu G, Levy A, Anantha S, Newman E, Karpeh MS Jr, Nealon W, Deutsch GB, Weiss MJ, DePeralta DK. Ampullary Neuroendocrine Tumors: Insight into a Rare Histology. Ann Surg Oncol 2021. [PMID: 34312800 DOI: 10.1245/s10434-021-10371-w] [Reference Citation Analysis]